e-learning
resources
Berlin 2001
Sunday 23.09.2001
Basic abnormalities and implication for treatment in cystic fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early signs of MMP/TIMP imbalance in cystic fibrosis
J. Braun, M. Hartog, J. Wermelt, K. Paul, K. Dalhoff, F. Ratjen (Lübeck, Berlin, Essen, Germany)
Source:
Annual Congress 2001 - Basic abnormalities and implication for treatment in cystic fibrosis
Session:
Basic abnormalities and implication for treatment in cystic fibrosis
Session type:
Oral Presentation
Number:
156
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Braun, M. Hartog, J. Wermelt, K. Paul, K. Dalhoff, F. Ratjen (Lübeck, Berlin, Essen, Germany). Early signs of MMP/TIMP imbalance in cystic fibrosis. Eur Respir J 2001; 16: Suppl. 31, 156
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Endothelial dysfunction in cystic fibrosis: imbalance NOS/arginase?
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007
Nutritional intervention in cystic fibrosis
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=153
Year: 2003
Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014
17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Clinical correlation of epithelial barrier dysfunction related to neutrophilic inflammation in cystic fibrosis
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Early renal involvement in children with cystic fibrosis.
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Correlation between inflammatory and oxidation markers in adults with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects
Year: 2008
Microcirculation alterations in adult patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 262s
Year: 2006
Premature vascular ageing in cystic fibrosis
Source: Eur Respir J 2009; 34: 1217-1218
Year: 2009
Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Ectopic subpleural fat deposition in idiopathic pulmonary fibrosis correlates with radiographic extension of fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Mechanisms and markers of airway inflammation in cystic fibrosis
Source: Eur Respir J 2002; 19: 333-340
Year: 2002
Airway inflammation in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 14-31
Year: 2014
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Aetiology of non cystic fibrosis bronchiectasis and its correlation with the site of pulmonary damage
Source: Eur Respir J 2003; 22: Suppl. 45, 504s
Year: 2003
Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014
Arginase in patients with cystic fibrosis airway disease
Source: Annual Congress 2004 - Cystic fibrosis in the 21
st
century: cutting edge investigations, taxing problems
Year: 2004
Acute exercise in cystic fibrosis patients increases neutrophilic pulmonary inflammation
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012
The ageing cystic fibrosis patient
Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept